Elderly show equally strong antibody response to first dose of Astra, Pfizer Covid-19 shots
A critical component of the immune system known as T cells showed a more enhanced response in those who got the AstraZeneca vaccine than in those who got the Pfizer one
AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
The first study to directly compare immune reactions between Pfizer's and AstraZeneca's Covid-19 vaccines has found similarly strong antibody responses in over 80-year-olds after a first dose of either shot, UK scientists said on Wednesday.
The study also found, however, that a critical component of the immune system known as T cells showed a more enhanced response in those who got the AstraZeneca vaccine than in those who got the Pfizer one - a finding scientists behind the study called worthy of more investigation.
Keep updated, follow The Business Standard's Google news channel
